熱門資訊> 正文
Monopar Therapeutics将实施1比5反向股票分割
2024-08-09 20:29
- Monopar Therapeutics (NASDAQ:MNPR) said it will effect a 1-for-5 reverse stock split of its outstanding shares of common stock.
- The company said that the reverse stock split is an effort to regain compliance with Nasdaq's listing rules.
More on Monopar Therapeutics
- Seeking Alpha’s Quant Rating on Monopar Therapeutics
- Historical earnings data for Monopar Therapeutics
- Financial information for Monopar Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。